Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.
暂无分享,去创建一个
[1] Svend K. Petersen-Mahrt,et al. Activation-Induced Deaminase , 2018, eLS.
[2] Xiaojiang S. Chen,et al. The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination. , 2016, Journal of molecular biology.
[3] L. Pedersen,et al. Structural analysis of the activation-induced deoxycytidine deaminase required in immunoglobulin diversification. , 2016, DNA repair.
[4] R. König,et al. APOBEC4 Enhances the Replication of HIV-1 , 2016, PloS one.
[5] O. Dussurget,et al. Cytosolic Innate Immune Sensing and Signaling upon Infection , 2016, Front. Microbiol..
[6] M. Weitzman,et al. APOBEC3A damages the cellular genome during DNA replication , 2016, Cell cycle.
[7] J. Chaudhuri,et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity , 2016, Nature Reviews Immunology.
[8] P. Mieczkowski,et al. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication. , 2016, Cell reports.
[9] Haixu Tang,et al. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli , 2016, Proceedings of the National Academy of Sciences.
[10] S. Antonarakis,et al. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication , 2016, Genome research.
[11] P. Gearhart,et al. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases. , 2016, DNA repair.
[12] P. Hanawalt,et al. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair , 2016, Cell.
[13] J. Jiricny,et al. Non-canonical uracil processing in DNA gives rise to double-strand breaks and deletions: relevance to class switch recombination , 2016, Nucleic acids research.
[14] D. Rueda,et al. Activation-induced deoxycytidine deaminase (AID) co-transcriptional scanning at single-molecule resolution , 2015, Nature Communications.
[15] Kin Chan,et al. Clusters of Multiple Mutations: Incidence and Molecular Mechanisms. , 2015, Annual review of genetics.
[16] A. Rosenspire,et al. Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens , 2015, Front. Immunol..
[17] G. Barber. STING: infection, inflammation and cancer , 2015, Nature Reviews Immunology.
[18] L. Notarangelo,et al. Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance. , 2015, Immunity.
[19] S. Ross,et al. APOBEC3 Proteins in Viral Immunity , 2015, The Journal of Immunology.
[20] Steven A. Roberts,et al. APOBEC-Induced Cancer Mutations Are Uniquely Enriched in Early-Replicating, Gene-Dense, and Active Chromatin Regions. , 2015, Cell reports.
[21] Rebecca M. McDougle,et al. The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers. , 2015, Cancer research.
[22] O. Elemento,et al. DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID. , 2015, Cell reports.
[23] M. Carpenter,et al. Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain* , 2015, The Journal of Biological Chemistry.
[24] A. Bhagwat,et al. Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine. , 2015, Journal of molecular biology.
[25] J. Li,et al. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review) , 2015, Molecular medicine reports.
[26] Chi H Mak,et al. Random-walk enzymes. , 2015, Physical review. E, Statistical, nonlinear, and soft matter physics.
[27] N. Maizels,et al. Cell Cycle Regulates Nuclear Stability of AID and Determines the Cellular Response to AID , 2015, PLoS genetics.
[28] Gad Getz,et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers , 2015, Nature Genetics.
[29] L. Willems,et al. APOBEC3 Interference during Replication of Viral Genomes , 2015, Viruses.
[30] G. Sethi,et al. Analysis of the intricate relationship between chronic inflammation and cancer. , 2015, The Biochemical journal.
[31] J. Chaudhuri,et al. Non-coding RNA Generated following Lariat Debranching Mediates Targeting of AID to DNA , 2015, Cell.
[32] C. Schiffer,et al. The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization. , 2015, Structure.
[33] C. Schiffer,et al. Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G , 2015, Nature Structural &Molecular Biology.
[34] J. Dudley,et al. APOBECs and virus restriction. , 2015, Virology.
[35] Igor B. Rogozin,et al. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes , 2015, PLoS genetics.
[36] S. Patnaik,et al. APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages , 2015, Nature Communications.
[37] H. Lucas,et al. Catalytic pocket inaccessibility of activation-induced cytidine deaminase is a safeguard against excessive mutagenic activity. , 2015, Structure.
[38] Dong Young Kim. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation , 2015, Archives of pharmacal research.
[39] S. Horswell,et al. APOBEC3A Is Implicated in a Novel Class of G-to-A mRNA Editing in WT1 Transcripts , 2015, PloS one.
[40] Vasco M. Barreto,et al. Activation-induced cytidine deaminase and active DNA demethylation. , 2015, Trends in biochemical sciences.
[41] Kevin M. McBride,et al. Absence of the Uracil DNA Glycosylase of Murine Gammaherpesvirus 68 Impairs Replication and Delays the Establishment of Latency In Vivo , 2015, Journal of Virology.
[42] V. C. Vieira,et al. Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B , 2014, mBio.
[43] C. E. Schrader,et al. IgH Chain Class Switch Recombination: Mechanism and Regulation , 2014, The Journal of Immunology.
[44] A. Bhagwat,et al. Transcription-associated mutagenesis. , 2014, Annual review of genetics.
[45] M. Santiago,et al. APOBEC3A Functions as a Restriction Factor of Human Papillomavirus , 2014, Journal of Virology.
[46] A. Moris,et al. AID and APOBECs span the gap between innate and adaptive immunity , 2014, Front. Microbiol..
[47] A. Clark,et al. A big surprise in the little zygote: the curious business of losing methylated cytosines. , 2014, Cell stem cell.
[48] Kazuyuki Aihara,et al. APOBEC3D and APOBEC3F Potently Promote HIV-1 Diversification and Evolution in Humanized Mouse Model , 2014, PLoS pathogens.
[49] HaroldC. Smith,et al. Structural insights for HIV-1 therapeutic strategies targeting Vif. , 2014, Trends in biochemical sciences.
[50] L. Chelico,et al. Suppression of APOBEC3-mediated restriction of HIV-1 by Vif , 2014, Front. Microbiol..
[51] Alberto Martin,et al. Genomic Uracil Homeostasis during Normal B Cell Maturation and Loss of This Balance during B Cell Cancer Development , 2014, Molecular and Cellular Biology.
[52] R. Rabadán,et al. Noncoding RNA transcription targets AID to divergently transcribed loci in B cells , 2014, Nature.
[53] C. Sala,et al. Erratum: The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas , 2014, Genome Biology.
[54] Peter J. Huwe,et al. High-throughput mutagenesis reveals functional determinants for DNA targeting by activation-induced deaminase , 2014, Nucleic acids research.
[55] S. Henderson,et al. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. , 2014, Cell reports.
[56] Y. Lyubchenko,et al. Interaction of APOBEC3A with DNA Assessed by Atomic Force Microscopy , 2014, PloS one.
[57] G. Victora,et al. Clonal and cellular dynamics in germinal centers. , 2014, Current opinion in immunology.
[58] S. Hubbard,et al. A DNA Sequence Recognition Loop on APOBEC3A Controls Substrate Specificity , 2014, PloS one.
[59] H. Aydin,et al. Structure-guided analysis of the human APOBEC3-HIV restrictome. , 2014, Structure.
[60] J. V. Moran,et al. APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition , 2014, eLife.
[61] Xavier Robert,et al. Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..
[62] M. Douglas,et al. Virus induced inflammation and cancer development. , 2014, Cancer letters.
[63] S. Wain-Hobson,et al. Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics , 2014, British Journal of Cancer.
[64] Ryan C. Burdick,et al. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. , 2014, Journal of molecular biology.
[65] R. Harris,et al. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells. , 2014, Journal of molecular biology.
[66] T. Liang,et al. Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA , 2014, Science.
[67] L. Chelico,et al. Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms , 2014, PLoS pathogens.
[68] B. Vogelstein,et al. Activation of PI3Kα by physiological effectors and by oncogenic mutations: structural and dynamic effects , 2014, Biophysical Reviews.
[69] G. Cao,et al. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. , 2014, Cancer letters.
[70] X. Ji,et al. Biochemical and Biological Studies of Mouse APOBEC3 , 2014, Journal of Virology.
[71] M. Yokoyama,et al. APOBEC3G Oligomerization Is Associated with the Inhibition of Both Alu and LINE-1 Retrotransposition , 2013, PloS one.
[72] M. McGarvey,et al. The inhibition of hepatitis B virus by APOBEC cytidine deaminases , 2013, Journal of viral hepatitis.
[73] M. Muramatsu,et al. APOBEC3 Deaminases Induce Hypermutation in Human Papillomavirus 16 DNA upon Beta Interferon Stimulation , 2013, Journal of Virology.
[74] Rommie E. Amaro,et al. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution. , 2013, Journal of molecular biology.
[75] Jeffrey E. Lee,et al. Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F , 2013, Nature Communications.
[76] Henning Hofmann,et al. Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity , 2013, Nucleic acids research.
[77] M. Muramatsu,et al. Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID) , 2013, The Journal of Biological Chemistry.
[78] Igor B. Rogozin,et al. Genome-Wide Mutation Avalanches Induced in Diploid Yeast Cells by a Base Analog or an APOBEC Deaminase , 2013, PLoS genetics.
[79] L. Loeb,et al. APOBEC3B mutagenesis in cancer , 2013, Nature Genetics.
[80] M. Goodman,et al. A Biochemical Analysis Linking APOBEC3A to Disparate HIV-1 Restriction and Skin Cancer* , 2013, The Journal of Biological Chemistry.
[81] M. Goodman,et al. A Mathematical Model for Scanning and Catalysis on Single-stranded DNA, Illustrated with Activation-induced Deoxycytidine Deaminase*♦ , 2013, The Journal of Biological Chemistry.
[82] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[83] D. Boffelli,et al. Activation-induced cytidine deaminase (AID) is necessary for the epithelial–mesenchymal transition in mammary epithelial cells , 2013, Proceedings of the National Academy of Sciences.
[84] N. A. Temiz,et al. Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.
[85] Steven A. Roberts,et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.
[86] V. C. Vieira,et al. The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections , 2013, BioMed research international.
[87] S. Wain-Hobson,et al. Efficient Deamination of 5-Methylcytidine and 5-Substituted Cytidine Residues in DNA by Human APOBEC3A Cytidine Deaminase , 2013, PloS one.
[88] J. Couture,et al. Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses , 2013, Nucleic acids research.
[89] C. Schiffer,et al. Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain. , 2013, Structure.
[90] O. Elemento,et al. AID stabilizes stem cell phenotype by removing epigenetic memory of pluripotency genes , 2013, Nature.
[91] M. Davenport,et al. Footprint of APOBEC3 on the Genome of Human Retroelements , 2013, Journal of Virology.
[92] E. Greene,et al. How do proteins locate specific targets in DNA? , 2013, Chemical physics letters.
[93] T. Tuschl,et al. A comprehensive analysis of AID's effects on the transcriptome and methylome of activated B cells , 2013, Nature Immunology.
[94] A. Gronenborn,et al. NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity , 2013, Nature Communications.
[95] Lela Lackey,et al. Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic* , 2013, The Journal of Biological Chemistry.
[96] D. Huang,et al. Interleukin-2 Inhibits HIV-1 Replication in Some Human T Cell Lymphotrophic Virus-1-infected Cell Lines via the Induction and Incorporation of APOBEC3G into the Virion* , 2013, The Journal of Biological Chemistry.
[97] M. Stratton,et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis , 2013, eLife.
[98] L. Notarangelo,et al. Immunodeficiency with Autoimmunity: Beyond the Paradox , 2013, Front. Immunol..
[99] 川俣 豊隆. Activation-induced cytidine deaminase(AID)を介するメシル酸イマチニブのB細胞分化抑制作用の解析 , 2013 .
[100] H. Blau,et al. A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] Jason B. Nikas,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[102] Kefei Yu,et al. Apurinic/Apyrimidinic Endonuclease 1 Is the Essential Nuclease during Immunoglobulin Class Switch Recombination , 2013, Molecular and Cellular Biology.
[103] D. Gordenin,et al. Base Damage within Single-Strand DNA Underlies In Vivo Hypermutability Induced by a Ubiquitous Environmental Agent , 2012, PLoS genetics.
[104] M. Malim,et al. Suppression of HIV-1 Infection by APOBEC3 Proteins in Primary Human CD4+ T Cells Is Associated with Inhibition of Processive Reverse Transcription as Well as Excessive Cytidine Deamination , 2012, Journal of Virology.
[105] W. Sugiura,et al. The APOBEC3C crystal structure and the interface for HIV-1 Vif binding , 2012, Nature Structural &Molecular Biology.
[106] Cindy Follonier,et al. Noncanonical mismatch repair as a source of genomic instability in human cells. , 2012, Molecular cell.
[107] Nina M. Donghia,et al. Activation-Induced Cytidine Deaminase-Initiated Off-Target DNA Breaks Are Detected and Resolved during S Phase , 2012, The Journal of Immunology.
[108] Svend K. Petersen-Mahrt,et al. AID Enzymatic Activity Is Inversely Proportional to the Size of Cytosine C5 Orbital Cloud , 2012, PloS one.
[109] Huixin Xu,et al. Biochemical Analysis of Hypermutation by the Deoxycytidine Deaminase APOBEC3A* , 2012, The Journal of Biological Chemistry.
[110] A. Bhagwat,et al. Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G , 2012, Nucleic acids research.
[111] Huijue Jia,et al. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation , 2012, Nature chemical biology.
[112] Steven A. Roberts,et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. , 2012, Molecular cell.
[113] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[114] Adrian L. Smith,et al. Ectopic restriction of DNA repair reveals that UNG2 excises AID-induced uracils predominantly or exclusively during G1 phase , 2012, The Journal of experimental medicine.
[115] V. Simon,et al. APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1 , 2012, Journal of Virology.
[116] T. Upton,et al. Single-stranded DNA Scanning and Deamination by APOBEC3G Cytidine Deaminase at Single Molecule Resolution*♦ , 2012, The Journal of Biological Chemistry.
[117] T. Kawaguchi,et al. Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes , 2012, Proceedings of the National Academy of Sciences.
[118] Rahul M Kohli,et al. The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential. , 2012, ACS chemical biology.
[119] Keiichiro Suzuki,et al. Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age , 2011, PloS one.
[120] Michel C. Nussenzweig,et al. Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes , 2011, Cell.
[121] Stefano Monti,et al. Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells , 2011, Cell.
[122] Chuan He,et al. Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.
[123] J. Darlix,et al. APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells , 2011, PLoS pathogens.
[124] G. Barber. Cytoplasmic DNA innate immune pathways , 2011, Immunological Reviews.
[125] Lela Lackey,et al. Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1 , 2011, Journal of Virology.
[126] M. Emerman,et al. The Breadth of Antiviral Activity of Apobec3DE in Chimpanzees Has Been Driven by Positive Selection , 2011, Journal of Virology.
[127] Shou-Jiang Gao,et al. Viruses and human cancer: from detection to causality. , 2011, Cancer letters.
[128] F. Rieux-Laucat,et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans , 2011, Proceedings of the National Academy of Sciences.
[129] G. Kelsoe,et al. Activation-induced cytidine deaminase mediates central tolerance in B cells , 2011, Proceedings of the National Academy of Sciences.
[130] A. Meyerhans,et al. Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo , 2011, Journal of Virology.
[131] M. Goodman,et al. Analysis of a Single-stranded DNA-scanning Process in Which Activation-induced Deoxycytidine Deaminase (AID) Deaminates C to U Haphazardly and Inefficiently to Ensure Mutational Diversity*♦ , 2011, The Journal of Biological Chemistry.
[132] F. Alt,et al. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. , 2011, Annual review of immunology.
[133] F. Alt,et al. The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates , 2011, Cell.
[134] Olivier Michielin,et al. Structure-Function Analyses Point to a Polynucleotide-Accommodating Groove Essential for APOBEC3A Restriction Activities , 2010, Journal of Virology.
[135] Y. Lyubchenko,et al. Atomic Force Microscopy Studies Provide Direct Evidence for Dimerization of the HIV Restriction Factor APOBEC3G* , 2010, The Journal of Biological Chemistry.
[136] Michael M. Mwangi,et al. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA editing targets in transcript 3′ UTRs , 2010, Nature Structural &Molecular Biology.
[137] B. Roche,et al. Deoxyuridine Triphosphate Incorporation during Somatic Hypermutation of Mouse VkOx Genes after Immunization with Phenyloxazolone , 2010, The Journal of Immunology.
[138] L. Wysocki,et al. Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity , 2010, The Journal of experimental medicine.
[139] T. Nakajima,et al. No evidence of an association between the APOBEC3B deletion polymorphism and susceptibility to HIV infection and AIDS in Japanese and Indian populations. , 2010, The Journal of infectious diseases.
[140] M. Matsuoka,et al. APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo , 2010, Journal of Virology.
[141] M. Carpenter,et al. Determinants of sequence-specificity within human AID and APOBEC3G. , 2010, DNA repair.
[142] J Kitaura,et al. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model , 2010, Leukemia.
[143] W. Brown,et al. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction , 2010, Nucleic acids research.
[144] D. Erie,et al. Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G*♦ , 2010, The Journal of Biological Chemistry.
[145] B. Zheng,et al. Deficiency in activation‐induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background , 2010, Clinical and experimental immunology.
[146] M. Neuberger,et al. Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID , 2010, The Journal of experimental medicine.
[147] M. Stenglein,et al. APOBEC3 proteins mediate the clearance of foreign DNA from human cells , 2010, Nature Structural &Molecular Biology.
[148] J. Tavernier,et al. Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis , 2009, Nucleic acids research.
[149] M. Cook,et al. Dysregulation of germinal centres in autoimmune disease , 2009, Nature Reviews Immunology.
[150] W. Grizzle,et al. Increased Expression of Activation‐Induced Cytidine Deaminase is Associated with Anti‐CCP and Rheumatoid Factor in Rheumatoid Arthritis , 2009, Scandinavian journal of immunology.
[151] M. Malim,et al. Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets , 2009, Journal of Virology.
[152] H. Matsuo,et al. An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model. , 2009, Journal of molecular biology.
[153] R. Maul,et al. A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase* , 2009, The Journal of Biological Chemistry.
[154] V. Pathak,et al. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA , 2009, Retrovirology.
[155] David R. Liu,et al. Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .
[156] M. Weitzman,et al. Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase , 2009, PLoS pathogens.
[157] M. Goodman,et al. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[158] Sridevi Devaraj,et al. Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. , 2009, Clinical chemistry.
[159] G. Superti-Furga,et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome , 2009, Nature Immunology.
[160] M. Malim,et al. RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1 , 2009, PLoS pathogens.
[161] S. Yokoyama,et al. Structure, interaction and real‐time monitoring of the enzymatic reaction of wild‐type APOBEC3G , 2009, The EMBO journal.
[162] Chuancang Jiang,et al. Activation‐induced deaminase heterozygous MRL/lpr mice are delayed in the production of high‐affinity pathogenic antibodies and in the development of lupus nephritis , 2009, Immunology.
[163] A. Bhagwat,et al. Transcriptional pausing and stalling causes multiple clustered mutations by human activation‐induced deaminase , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[164] M. Nussenzweig,et al. AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.
[165] M. Malim,et al. APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts , 2008, PLoS pathogens.
[166] V. Pathak,et al. Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif , 2008, Journal of Virology.
[167] R. Stevens,et al. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications , 2008, Nature.
[168] S. O’Brien,et al. Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins , 2008, Journal of Virology.
[169] Toshihiro Sato,et al. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif , 2008, Nature Structural &Molecular Biology.
[170] M. Kotler,et al. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase , 2008, Nature Structural &Molecular Biology.
[171] M. Emerman,et al. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. , 2008, Cell host & microbe.
[172] T. Honjo,et al. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. , 2008, Gastroenterology.
[173] K. Itoh,et al. Activation-Induced Cytidine Deaminase Deficiency Causes Organ-Specific Autoimmune Disease , 2008, PloS one.
[174] B. Wright,et al. I. VH gene transcription creates stabilized secondary structures for coordinated mutagenesis during somatic hypermutation. , 2008, Molecular immunology.
[175] B. Wright,et al. II. Correlations between secondary structure stability and mutation frequency during somatic hypermutation. , 2008, Molecular immunology.
[176] Bryan R. G. Williams,et al. Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.
[177] K. Strebel,et al. HIV-1 Vif, APOBEC, and Intrinsic Immunity , 2008, Retrovirology.
[178] S. Conticello. The AID/APOBEC family of nucleic acid mutators , 2008, Genome Biology.
[179] D. Erie,et al. A Model for Oligomeric Regulation of APOBEC3G Cytosine Deaminase-dependent Restriction of HIV* , 2008, Journal of Biological Chemistry.
[180] S. Wain-Hobson,et al. Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions , 2008, Science.
[181] C. E. Schrader,et al. Mechanism and regulation of class switch recombination. , 2008, Annual review of immunology.
[182] Colin R. Parrish,et al. Presence and role of cytosine methylation in DNA viruses of animals , 2008, Nucleic acids research.
[183] H. Matsuo,et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G , 2008, Nature.
[184] M. Khan,et al. HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes. , 2008, Virology.
[185] Jialing Huang,et al. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. , 2008, The Journal of general virology.
[186] D. Schatz,et al. Two levels of protection for the B cell genome during somatic hypermutation , 2008, Nature.
[187] E. Selsing,et al. Activation-Induced Cytidine Deaminase-Dependent DNA Breaks in Class Switch Recombination Occur during G1 Phase of the Cell Cycle and Depend upon Mismatch Repair1 , 2007, The Journal of Immunology.
[188] Jialing Huang,et al. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. , 2007, Virology.
[189] R. Medzhitov. Recognition of microorganisms and activation of the immune response , 2007, Nature.
[190] A. Gronenborn,et al. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G , 2007, Nucleic acids research.
[191] T. Honjo,et al. Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling , 2007, Oncogene.
[192] K. Honda,et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.
[193] M. Neuberger,et al. Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.
[194] G. Kissling,et al. Abrogation of Lupus Nephritis in Activation-Induced Deaminase-Deficient MRL/lpr Mice1 , 2007, The Journal of Immunology.
[195] W. Reik. Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.
[196] W. Grizzle,et al. Overexpression of Activation-Induced Cytidine Deaminase in B Cells Is Associated with Production of Highly Pathogenic Autoantibodies1 , 2007, The Journal of Immunology.
[197] P. Spearman,et al. APOBEC3G Multimers Are Recruited to the Plasma Membrane for Packaging into Human Immunodeficiency Virus Type 1 Virus-Like Particles in an RNA-Dependent Process Requiring the NC Basic Linker , 2007, Journal of Virology.
[198] M. Malim,et al. APOBEC-mediated viral restriction: not simply editing? , 2007, Trends in biochemical sciences.
[199] G. Heidecker,et al. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid , 2007, Proceedings of the National Academy of Sciences.
[200] M. Malim,et al. APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation , 2007, Journal of Biological Chemistry.
[201] M. Klein,et al. The APOBEC-2 crystal structure and functional implications for the deaminase AID , 2007, Nature.
[202] M. Neuberger,et al. Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase η for A/T , 2007, The Journal of experimental medicine.
[203] J. Wedekind,et al. Nanostructures of APOBEC3G Support a Hierarchical Assembly Model of High Molecular Mass Ribonucleoprotein Particles from Dimeric Subunits* , 2006, Journal of Biological Chemistry.
[204] W. Greene,et al. Distinct Patterns of Cytokine Regulation of APOBEC3G Expression and Activity in Primary Lymphocytes, Macrophages, and Dendritic Cells* , 2006, Journal of Biological Chemistry.
[205] D. Nicolae,et al. Somatic Hypermutation and Class Switch Recombination in Msh6−/−Ung−/− Double-Knockout Mice1 , 2006, The Journal of Immunology.
[206] M. Neuberger,et al. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2 −/− ung −/− mice , 2006, The Journal of experimental medicine.
[207] J. Löwer,et al. APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition* , 2006, Journal of Biological Chemistry.
[208] M. O’Donnell,et al. DNA replication: keep moving and don't mind the gap. , 2006, Molecular cell.
[209] P. Casali,et al. DNA repair in antibody somatic hypermutation. , 2006, Trends in immunology.
[210] M. Stenglein,et al. APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism* , 2006, Journal of Biological Chemistry.
[211] D. Parkin,et al. The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.
[212] J. V. Moran,et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[213] S. Wain-Hobson,et al. Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication , 2006, Hepatology.
[214] M. Goodman,et al. APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA , 2006, Nature Structural &Molecular Biology.
[215] H. Seno,et al. Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes , 2006 .
[216] C. Lilley,et al. APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons , 2006, Current Biology.
[217] S. Wahl,et al. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti–HIV-1 activity , 2006, The Journal of experimental medicine.
[218] S. Calattini,et al. Restriction of Foamy Viruses by APOBEC Cytidine Deaminases , 2006, Journal of Virology.
[219] A. Reymond,et al. Emergence of Young Human Genes after a Burst of Retroposition in Primates , 2005, PLoS biology.
[220] B. Cullen,et al. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. , 2005, Virology.
[221] C. E. Schrader,et al. Inducible DNA breaks in Ig S regions are dependent on AID and UNG , 2005, The Journal of experimental medicine.
[222] E. Koonin,et al. APOBEC4, a New Member of the AID/APOBEC Family of Polynucleotide (Deoxy)Cytidine Deaminases Predicted by Computational Analysis , 2005, Cell cycle.
[223] B. Cullen,et al. Foamy Virus Bet Proteins Function as Novel Inhibitors of the APOBEC3 Family of Innate Antiretroviral Defense Factors , 2005, Journal of Virology.
[224] Robert E. Johnson,et al. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. , 2005, Annual review of biochemistry.
[225] S. Wain-Hobson,et al. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[226] Amane Sasada,et al. APOBEC3G targets human T-cell leukemia virus type 1 , 2005, Retrovirology.
[227] W. Reik,et al. Epigenetic reprogramming in mammals. , 2005, Human molecular genetics.
[228] B. Cullen,et al. Inhibition of a Yeast LTR Retrotransposon by Human APOBEC3 Cytidine Deaminases , 2005, Current Biology.
[229] T. Honjo,et al. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[230] Alberto Martin,et al. Methylation protects cytidines from AID-mediated deamination. , 2005, Molecular immunology.
[231] T. Heidmann,et al. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses , 2005, Nature.
[232] R. König,et al. APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication* , 2004, Journal of Biological Chemistry.
[233] Wendy Dean,et al. Activation-induced Cytidine Deaminase Deaminates 5-Methylcytosine in DNA and Is Expressed in Pluripotent Tissues , 2004, Journal of Biological Chemistry.
[234] Myron F. Goodman,et al. Biochemical Analysis of Hypermutational Targeting by Wild Type and Mutant Activation-induced Cytidine Deaminase* , 2004, Journal of Biological Chemistry.
[235] L. Pasqualucci,et al. Expression of the AID protein in normal and neoplastic B cells. , 2004, Blood.
[236] Reuben S. Harris,et al. Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.
[237] Ash A. Alizadeh,et al. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity , 2004, Leukemia.
[238] M. Neuberger,et al. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. , 2004, Molecular cell.
[239] N. Bannert,et al. Retroelements and the human genome: New perspectives on an old relation , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[240] M. Marin,et al. Transcriptional Regulation of APOBEC3G, a Cytidine Deaminase That Hypermutates Human Immunodeficiency Virus* , 2004, Journal of Biological Chemistry.
[241] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[242] U. Storb,et al. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[243] M. Nussenzweig,et al. AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.
[244] J. Marko,et al. How do site-specific DNA-binding proteins find their targets? , 2004, Nucleic acids research.
[245] Tae-Min Kim,et al. Periodic Explosive Expansion of Human Retroelements Associated with the Evolution of the Hominoid Primate , 2004, Journal of Korean medical science.
[246] H. Ohno,et al. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL , 2004, Leukemia.
[247] Reuben S Harris,et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. , 2004, Journal of molecular biology.
[248] F. Alt,et al. Induction of Activation-induced Cytidine Deaminase Gene Expression by Il-4 and Cd40 Ligation Is Dependent on Stat6 and Nfkb , 2022 .
[249] A. Bhagwat. DNA-cytosine deaminases: from antibody maturation to antiviral defense. , 2004, DNA repair.
[250] Y. Yokota,et al. Transcription-Coupled Events Associating with Immunoglobulin Switch Region Chromatin , 2003, Science.
[251] Reuben S Harris,et al. The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G , 2003, Current Biology.
[252] Yunkai Yu,et al. Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.
[253] M. Malim,et al. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif , 2003, Nature Medicine.
[254] E. Eichler,et al. An Alu transposition model for the origin and expansion of human segmental duplications. , 2003, American journal of human genetics.
[255] M. Potter. Neoplastic development in plasma cells , 2003, Immunological reviews.
[256] R. Bende,et al. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. , 2003, Cancer research.
[257] R. König,et al. Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.
[258] Gersende Caron,et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.
[259] Hui Zhang,et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.
[260] M. Goodman,et al. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation , 2003, Nature.
[261] A. Bhagwat,et al. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. , 2003, Nucleic acids research.
[262] Reuben S Harris,et al. Immunity through DNA deamination. , 2003, Trends in biochemical sciences.
[263] M. Neuberger,et al. In Vitro Deamination of Cytosine to Uracil in Single-stranded DNA by Apolipoprotein B Editing Complex Catalytic Subunit 1 (APOBEC1)* , 2003, Journal of Biological Chemistry.
[264] F. Papavasiliou,et al. AID Mediates Hypermutation by Deaminating Single Stranded DNA , 2003, The Journal of experimental medicine.
[265] N. Kakazu,et al. Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.
[266] W. Klapper,et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.
[267] F. Alt,et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme , 2003, Nature.
[268] M. Goodman,et al. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[269] F. Drabløs,et al. Uracil in DNA – occurrence, consequences and repair , 2002, Oncogene.
[270] Reuben S Harris,et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.
[271] D. Barnes,et al. Immunoglobulin Isotype Switching Is Inhibited and Somatic Hypermutation Perturbed in UNG-Deficient Mice , 2002, Current Biology.
[272] M. Malim,et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.
[273] M. Neuberger,et al. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.
[274] M. Neuberger,et al. AID Is Essential for Immunoglobulin V Gene Conversion in a Cultured B Cell Line , 2002, Current Biology.
[275] I. Dunham,et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. , 2002, Genomics.
[276] T. Honjo,et al. Activation-induced Deaminase (AID)-directed Hypermutation in the Immunoglobulin Sμ Region , 2002, The Journal of Experimental Medicine.
[277] Riccardo Dalla-Favera,et al. Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.
[278] P. Cramer,et al. Structural Basis of Transcription: An RNA Polymerase II Elongation Complex at 3.3 Å Resolution , 2001, Science.
[279] S. Paludan,et al. Molecular Pathways in Virus-Induced Cytokine Production , 2001, Microbiology and Molecular Biology Reviews.
[280] A. Fischer,et al. Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.
[281] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[282] F. Buck,et al. Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex* , 2000, The Journal of Biological Chemistry.
[283] F. Hanaoka,et al. Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.
[284] N. Sherman,et al. Molecular Cloning of Apobec-1 Complementation Factor, a Novel RNA-Binding Protein Involved in the Editing of Apolipoprotein B mRNA , 2000, Molecular and Cellular Biology.
[285] J. Butel,et al. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. , 2000, Carcinogenesis.
[286] C. Scheidereit,et al. NF-kappaB and the innate immune response. , 2000, Current opinion in immunology.
[287] R. Kucherlapati,et al. Reduced Isotype Switching in Splenic B Cells from Mice Deficient in Mismatch Repair Enzymes , 1999, The Journal of experimental medicine.
[288] I. Dunham,et al. Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. , 1999, The Journal of investigative dermatology.
[289] T. Honjo,et al. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.
[290] M. Neuberger,et al. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class‐switch recombination: parallels with somatic hypermutation , 1999, The EMBO journal.
[291] M. Shlomchik,et al. A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.
[292] L. Pasqualucci,et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[293] U. Storb,et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. , 1998, Science.
[294] J. Borén,et al. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[295] R. Tarone,et al. Increased Hypermutation at G and C Nucleotides in Immunoglobulin Variable Genes from Mice Deficient in the MSH2 Mismatch Repair Protein , 1998, The Journal of experimental medicine.
[296] T. Innerarity,et al. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. , 1997, Genes & development.
[297] A. Bhagwat,et al. Transcription-induced mutations: increase in C to T mutations in the nontranscribed strand during transcription in Escherichia coli. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[298] K. Rajewsky. Clonal selection and learning in the antibody system , 1996, Nature.
[299] U. Storb,et al. The molecular basis of somatic hypermutation of immunoglobulin genes. , 1996, Current opinion in immunology.
[300] J. Borén,et al. Biosynthesis of Apolipoprotein B48-containing Lipoproteins , 1996, The Journal of Biological Chemistry.
[301] G R Skuse,et al. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. , 1996, Nucleic acids research.
[302] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[303] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[304] R. L. Thompson,et al. Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system , 1994, Journal of virology.
[305] J. Morrison,et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. , 1993, The Journal of biological chemistry.
[306] J. Celis,et al. Evidence for an altered protein kinase C (PKC) signaling pathway in psoriasis. , 1993, The Journal of investigative dermatology.
[307] H. Greten,et al. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. , 1993, Journal of lipid research.
[308] C. Burant,et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.
[309] T. Lindahl. Instability and decay of the primary structure of DNA , 1993, Nature.
[310] D. Pisetsky,et al. The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. , 1993, Cellular immunology.
[311] G. Hertz,et al. DNA sequences at immunoglobulin switch region recombination sites. , 1993, Nucleic acids research.
[312] N A Kolchanov,et al. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. , 1992, Biochimica et biophysica acta.
[313] M. Potter,et al. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. , 1992, Carcinogenesis.
[314] J. Scott,et al. Apolipoprotein B mRNA editing: a new tier for the control of gene expression. , 1992, Trends in biochemical sciences.
[315] Z W Gu,et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.
[316] J. Glickman,et al. Apolipoprotein B synthesis by human liver and intestine in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[317] P. V. von Hippel,et al. Diffusion-driven mechanisms of protein translocation on nucleic acids. 1. Models and theory. , 1981, Biochemistry.
[318] J. Kane,et al. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[319] F. Burnet. A modification of jerne's theory of antibody production using the concept of clonal selection , 1976, CA: a cancer journal for clinicians.
[320] G. Getz,et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers , 2015, Nature Genetics.
[321] Uttiya Basu,et al. RNA Exosome Regulates AID DNA Mutator Activity in the B Cell Genome. , 2015, Advances in immunology.
[322] Chung-Pei Lee,et al. Uracil DNA Glycosylase BKRF3 Contributes to EBV DNA Replication , 2014 .
[323] C. Schiffer,et al. Methyl-and Normal-Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC 3 A , 2012 .
[324] M. Nussenzweig,et al. Activation-induced cytidine deaminase in antibody diversification and chromosome translocation. , 2012, Advances in cancer research.
[325] Y. Chiu. Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes. , 2011, Methods in molecular biology.
[326] M. Nussenzweig,et al. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes , 2011, Nature Immunology.
[327] D. Schatz,et al. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions , 2011, Nature Immunology.
[328] Jialing Huang,et al. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. , 2008, The Journal of general virology.
[329] L. Pasqualucci,et al. AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.
[330] D. Erie,et al. Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNA. , 2008, DNA repair.
[331] B. Ames,et al. An assay for uracil in human DNA at baseline: effect of marginal vitamin B6 deficiency. , 2008, Analytical biochemistry.
[332] T. Honjo,et al. Role of AID in tumorigenesis. , 2007, Advances in immunology.
[333] A. Koito,et al. Human T cell leukemia virus type I is resistant to the antiviral effects of APOBEC3. , 2007, Journal of virological methods.
[334] H. Seno,et al. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. , 2006, Biochemical and biophysical research communications.
[335] S. Wahl,et al. a defensive maneuver underlying interferon-induced anti-HIV-1 activity , 2006 .
[336] Jialing Huang,et al. CD 4 T Cells 1 Activity of APOBEC 3 G in Resting Primary Anti-Human Immunodeficiency Virus Type Alpha Interferon Potently Enhances the , 2006 .
[337] S. Wain-Hobson,et al. Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. , 2005, The Journal of general virology.
[338] A. Fischer,et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. , 2004, Clinical immunology.
[339] H. Ploegh,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003 .
[340] U. Storb,et al. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. , 1996, Immunity.
[341] C. Lawrence,et al. DNA polymerase zeta and the control of DNA damage induced mutagenesis in eukaryotes. , 1996, Cancer surveys.
[342] A. Goldsobel,et al. Allergy and immunology. , 1995, The Western journal of medicine.
[343] Xianghui Yu,et al. Induction of APOBEC 3 G Ubiquitination and Degradation by an HIV-1 Vif-Cul 5-SCF Complex , 2022 .